Table 7.
Laboratory Diagnosis of Encephalitis
Etiologic Agents | Diagnostic Procedures | Optimum Specimens | Transport Issues and Optimal Transport Time |
---|---|---|---|
Viral | |||
Herpes simplex virus | HSV-1 and -2 NAAT | CSF | Sterile container, RT, 2 h |
Enteroviruses (nonpolio) | Enterovirus NAAT | CSF | Sterile container, RT, 2 h |
Parechoviruses | Parechovirus NAAT | CSF | Sterile container, RT, 2 h |
West Nile virus | WNV IgM antibodya | CSF and/or serum | Closed container or clot tube, RT, 2 h |
WNV NAATb | CSF and/or serum | Sterile container, RT, 2 h | |
Other arbovirusesc | Virus specific antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h |
Varicella zoster virusd | VZV NAAT | CSF or plasma | Sterile container or EDTA tube, RT, 2 h |
VZV antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Epstein-Barr virus | EBV NAATe | CSF or plasma | Sterile container or EDTA tube, RT, 2 h |
EBV antibodies, VCA IgG and IgM, EBNA | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Cytomegalovirusf | CMV NAATg | CSF or plasma | Sterile container or EDTA tube, RT, 2 h |
CMV antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Human herpesvirus 6 | HHV-6 NAAT | CSF | Sterile container, RT, 2 h |
JC virus | JC virus NAAT | CSF | Sterile container, RT, 2 h |
Mumps virus | Mumps virus antibodies, IgM and IgG | Serum | Clot tube, RT, 2 h |
CSF | Closed container, RT, 2 h | ||
Mumps culture and NAAT | CSF | Sterile container, on ice, immediately | |
Buccal or oral swab | Viral transport device, on ice, immediately | ||
Measles (rubeola) virus | Measles antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h |
Measles culture and NAAT |
CSF, urine | Sterile container, RT, 2 h | |
Throat swab | Viral transport device, on ice, immediately | ||
Influenza virus | Influenza DFA and culture or NAAT | Nasopharyngeal wash or other respiratory specimen | Viral transport device, on ice, immediately |
Adenovirus | Adenovirus DFA and culture or NAAT | Nasopharyngeal wash or other respiratory specimen | Viral transport device, on ice, immediately |
Adenovirus NAAT | CSF or plasma | Sterile container or EDTA, RT, 2 h | |
Rabies virush | Rabies antigen, DFA | Nuchal skin biopsy | Closed container, RT, immediately |
Rabies NAAT | Saliva | Sterile container, RT, immediately | |
Rabies antibody | CSF and serum | Closed container, clot tube, RT, 2 h | |
Lymphocytic choriomeningitis virus | LCM antibodies, IgM and IgG, IFA | CSF and/or serum | Closed container or clot tube, RT, 2 h |
Zika virus (see Table 71) | |||
Bacterial | |||
Mycobacterium tuberculosis | See Table 6, Meningitis | ||
Bartonella spp | Bartonella spp NAAT | CSF or plasma | Sterile container or EDTA, RT, 2 h |
Bartonella spp antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Mycoplasma pneumoniae | M. pneumoniae NAAT | CSF or respiratory | Sterile container, RT, 2 h |
M. pneumoniae antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Tropheryma whipplei (Whipple disease) | T. whipplei NAAT | CSF | Sterile container, RT, 2 h |
Listeria monocytogenes | Gram stain Aerobic bacterial culture |
CSF, blood | Sterile container, aerobic blood culture bottle, RT, 2 h |
Listeria antibody, complement fixation | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Coxiella burnetii (Q fever) | C. burnetii antibodies, IgM and IgG | Serum | Clot tube, RT, 2 h |
C. burnetii NAAT | Whole blood | EDTA tube, RT, 2 h | |
Tissue | Sterile container, RT, 2 h | ||
Rickettsia rickettsii (RMSF), Rickettsia typhi | Rickettsia spp antibodies, IgG and IgM, IFA | CSF and/or serum | Closed container or clot tube, RT, 2 h |
R. rickettsii DFA or IHC and NAAT | Skin biopsy from rash | Sterile container, RT, 2 h | |
R. rickettsii NAAT | Whole blood | EDTA tube, RT, 2 h | |
Ehrlichia chaffeensis, Anaplasma phagocytophilum | E. chaffeensis and A. phagocytophilum antibodies, IgM and IgG | CSF and/or serum | Closed container or clot tube, RT, 2 h |
E. chaffeensis and A. phagocytophilum NAAT | Whole blood | EDTA tube, RT, 2 h | |
Other: B. burgdorferi, T. pallidum, Leptospira spp | See Table 6, Meningitis | ||
Fungal | |||
Cryptococcus neoformans |
Cryptococcus antigen test | CSF, serum | Closed container, clot tube, RT, 2 h |
Cryptococcus gattii | Gram stain Aerobic bacterial culture Fungal culture |
CSF | Sterile container, RT, 2 h |
Coccidioides spp | Coccidioides antibody, immunodiffusion, and complement fixatione | CSF and/or serum | Closed container or clot tube, RT, 2 h |
Calcofluor stain Fungal culture |
CSF, other sites | Sterile container, RT, 2 h | |
Histologic examination | Tissue or formalin-fixed tissue | Sterile container, RT, 2 h or formalin, indefinite | |
Parasitic | |||
Acanthamoeba spp Naegleria fowleri |
Microscopic wet mount Giemsa stain |
CSF | Closed container, RT, 2 h |
Histology (trichrome stain) | CSF, brain tissue | Closed container, RT, 2 h | |
Culture | CSF, brain tissue | Sterile container, RT, 2 h | |
Acanthamoeba antibody IFAi | Serum | Clot tube, RT, 2 h | |
Acanthamoeba IIF stainingi | Brain tissue | Closed container, RT, 2 h | |
Histology (trichrome stain) | Brain tissue | Closed container, RT, 2 h | |
Balamuthia mandrillaris | Balamuthia antibody, IFAi | Serum | Clot tube, RT, 2 h |
Balamuthia IIF stainingi | Brain tissue | Closed container, RT, 2 h | |
Baylisascaris procyonisj | B. procyonis antibodies | CSF and/or serum | Closed container or clot tube, RT, 2 h |
Trypanosoma brucei spp | Giemsa stain | CSF, brain tissue | Closed container, RT, 2 h |
Blood | EDTA tube, RT, 2 h | ||
Toxoplasma gondii | Toxoplasma NAAT | CSF, serum, plasma | Sterile container, clot tube, EDTA tube, RT, 2 h |
Toxoplasma antibodies, IgM and IgGk | CSF and/or serum | Closed container or clot tube, RT, 2 h | |
Giemsa stain, histology | CSF, brain tissue | Closed container, RT, 2 h | |
Prion | |||
Creutzfeldt-Jakob diseasel | 14-3-3 protein | CSF | Closed container, RT, 2 h |
Neuron-specific enolase | CSF | Closed container, RT, 2 h | |
Routine histology, immune stain for prion protein | Formalin-fixed brain tissue | Contact surgical pathologist prior to collection of tissuem | |
Western blot for prion protein | Frozen brain tissue | Contact surgical pathologist prior to collection of tissuem | |
PrP gene sequencing | Blood, other tissues | EDTA tube, sterile container, RT, 2 h |
Abbreviations: CMV, cytomegalovirus; CSF, cerebrospinal fluid; DFA, direct fluorescent antibody; EBNA, Epstein-Barr nuclear antigen; EBV, Epstein-Barr virus; EDTA, ethylenediaminetetraacetic acid; HHV-6, human herpesvirus type 6; HSV, herpes simplex virus; IFA, indirect fluorescent antibody; IgG, immunoglobulin G; IgM, immunoglobulin M; IHC, immunohistochemistry; IIF, indirect immunofluorescent antibody; LCM, lymphocytic choriomeningitis virus; NAAT, nucleic acid amplification testing; RMSF, Rocky Mountain spotted fever; RT, room temperature; VCA, viral capsid antigen; WNV, West Nile virus.
aWNV IgM antibody may persist for >6 months. False positives may occur with recent immunization (Japanese encephalitis, yellow fever) or other flavivirus infection (dengue, St Louis encephalitis, Zika) [30].
bSensitivity of WNV NAAT in immunocompetent host is <60% [30]. Testing for IgM in CSF is preferred, but may be falsely negative during first week of symptoms. Persistent viremia in immunocompromised hosts lacking serologic response may improve WNV NAAT sensitivity.
cEastern equine, Western equine, Lacrosse, St Louis, and California encephalitis viruses.
dDetection of VZV DNA in CSF (~60% of cases), CSF IgM, or intrathecal antibody synthesis distinguishes meningoencephalitis from postinfectious, immune-mediated process [27].
eQuantitative EBV NAAT may help distinguish true-positive from latent virus [27].
fCongenital disease in newborns and reactivation in immunocompromised hosts. False-positive CSF CMV NAAT results have been reported in immunocompetent patients with bacterial meningitis [27].
gIn human immunodeficiency virus–infected patients, detection of CMV DNA in CSF has 82%–100% sensitivity and 86%–100% specificity for diagnosing central nervous system CMV infection [27].
hContact state public health department to arrange testing; questions regarding sampling techniques and shipping may be directed to the Rabies section at the Centers for Disease Control and Prevention (CDC), telephone: (404) 639–1050.
iAvailable at the California State Department of Health Services and the CDC [31].
jConsider if eosinophilia or exposure to raccoon feces [32]. Testing available at the Department of Veterinary Pathobiology, Purdue University (West Lafayette, Indiana), telephone: (765) 494-7558.
kRefer positive IgM to Toxoplasma Serology Laboratory in Palo Alto, California, for confirmatory testing (http://www.pamf.org/serology/). The absence of serum IgM or IgG does not exclude Toxoplasma infection (22% of AIDS patients with Toxoplasma encephalitis lack IgG; IgM is rarely detected) [33].
lTesting available at the National Prion Disease Pathology Surveillance Center (http://www.cjdsurveillance.com) [34]. The 14-3-3 protein has limited specificity for prion disease.
mCompliance with appropriate infection control protocols is essential.